Global CAR T-Cell-Based Drug Market Research Report 2024, Forecast to 2032

October 2024 | 137 pages | ID: GBF198B9A48EEN
Bosson Research

Abstracts

Report Overview

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.

The global CAR T-Cell-Based Drug market size was estimated at USD 2806 million in 2023 and is projected to reach USD 28542.77 million by 2032, exhibiting a CAGR of 29.40% during the forecast period.

North America CAR T-Cell-Based Drug market size was estimated at USD 1146.10 million in 2023, at a CAGR of 25.20% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global CAR T-Cell-Based Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CAR T-Cell-Based Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CAR T-Cell-Based Drug market in any manner.

Global CAR T-Cell-Based Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Gilead Sciences

Bristol-Myers Squibb

J & J

JW Therapeutics

FOSUNKite

CARsgen Therapeutics

Autolus Therapeutics

Sorrento Therapeutics

Mustang Bio

Bluebird Bio

Cellectis

Allogene Therapeutics

Celyad

Market Segmentation (by Type)

CD19-targeted

BCMA-targeted

Market Segmentation (by Application)

Lymphoma

Multiple Myeloma

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the CAR T-Cell-Based Drug Market
• Overview of the regional outlook of the CAR T-Cell-Based Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CAR T-Cell-Based Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of CAR T-Cell-Based Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of CAR T-Cell-Based Drug
1.2 Key Market Segments
  1.2.1 CAR T-Cell-Based Drug Segment by Type
  1.2.2 CAR T-Cell-Based Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CAR T-CELL-BASED DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global CAR T-Cell-Based Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
  2.1.2 Global CAR T-Cell-Based Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CAR T-CELL-BASED DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Global CAR T-Cell-Based Drug Sales by Manufacturers (2019-2024)
3.2 Global CAR T-Cell-Based Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CAR T-Cell-Based Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers CAR T-Cell-Based Drug Sales Sites, Area Served, Product Type
3.6 CAR T-Cell-Based Drug Market Competitive Situation and Trends
  3.6.1 CAR T-Cell-Based Drug Market Concentration Rate
  3.6.2 Global 5 and 10 Largest CAR T-Cell-Based Drug Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CAR T-CELL-BASED DRUG INDUSTRY CHAIN ANALYSIS

4.1 CAR T-Cell-Based Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CAR T-CELL-BASED DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CAR T-Cell-Based Drug Sales Market Share by Type (2019-2024)
6.3 Global CAR T-Cell-Based Drug Market Size Market Share by Type (2019-2024)
6.4 Global CAR T-Cell-Based Drug Price by Type (2019-2024)

7 CAR T-CELL-BASED DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CAR T-Cell-Based Drug Market Sales by Application (2019-2024)
7.3 Global CAR T-Cell-Based Drug Market Size (M USD) by Application (2019-2024)
7.4 Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2019-2024)

8 CAR T-CELL-BASED DRUG MARKET CONSUMPTION BY REGION

8.1 Global CAR T-Cell-Based Drug Sales by Region
  8.1.1 Global CAR T-Cell-Based Drug Sales by Region
  8.1.2 Global CAR T-Cell-Based Drug Sales Market Share by Region
8.2 North America
  8.2.1 North America CAR T-Cell-Based Drug Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe CAR T-Cell-Based Drug Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific CAR T-Cell-Based Drug Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America CAR T-Cell-Based Drug Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa CAR T-Cell-Based Drug Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 CAR T-CELL-BASED DRUG MARKET PRODUCTION BY REGION

9.1 Global Production of CAR T-Cell-Based Drug by Region (2019-2024)
9.2 Global CAR T-Cell-Based Drug Revenue Market Share by Region (2019-2024)
9.3 Global CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America CAR T-Cell-Based Drug Production
  9.4.1 North America CAR T-Cell-Based Drug Production Growth Rate (2019-2024)
  9.4.2 North America CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe CAR T-Cell-Based Drug Production
  9.5.1 Europe CAR T-Cell-Based Drug Production Growth Rate (2019-2024)
  9.5.2 Europe CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan CAR T-Cell-Based Drug Production (2019-2024)
  9.6.1 Japan CAR T-Cell-Based Drug Production Growth Rate (2019-2024)
  9.6.2 Japan CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China CAR T-Cell-Based Drug Production (2019-2024)
  9.7.1 China CAR T-Cell-Based Drug Production Growth Rate (2019-2024)
  9.7.2 China CAR T-Cell-Based Drug Production, Revenue, Price and Gross Margin (2019-2024)

10 KEY COMPANIES PROFILE

10.1 Novartis
  10.1.1 Novartis CAR T-Cell-Based Drug Basic Information
  10.1.2 Novartis CAR T-Cell-Based Drug Product Overview
  10.1.3 Novartis CAR T-Cell-Based Drug Product Market Performance
  10.1.4 Novartis Business Overview
  10.1.5 Novartis CAR T-Cell-Based Drug SWOT Analysis
  10.1.6 Novartis Recent Developments
10.2 Gilead Sciences
  10.2.1 Gilead Sciences CAR T-Cell-Based Drug Basic Information
  10.2.2 Gilead Sciences CAR T-Cell-Based Drug Product Overview
  10.2.3 Gilead Sciences CAR T-Cell-Based Drug Product Market Performance
  10.2.4 Gilead Sciences Business Overview
  10.2.5 Gilead Sciences CAR T-Cell-Based Drug SWOT Analysis
  10.2.6 Gilead Sciences Recent Developments
10.3 Bristol-Myers Squibb
  10.3.1 Bristol-Myers Squibb CAR T-Cell-Based Drug Basic Information
  10.3.2 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
  10.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product Market Performance
  10.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug SWOT Analysis
  10.3.5 Bristol-Myers Squibb Business Overview
  10.3.6 Bristol-Myers Squibb Recent Developments
10.4 J and J
  10.4.1 J and J CAR T-Cell-Based Drug Basic Information
  10.4.2 J and J CAR T-Cell-Based Drug Product Overview
  10.4.3 J and J CAR T-Cell-Based Drug Product Market Performance
  10.4.4 J and J Business Overview
  10.4.5 J and J Recent Developments
10.5 JW Therapeutics
  10.5.1 JW Therapeutics CAR T-Cell-Based Drug Basic Information
  10.5.2 JW Therapeutics CAR T-Cell-Based Drug Product Overview
  10.5.3 JW Therapeutics CAR T-Cell-Based Drug Product Market Performance
  10.5.4 JW Therapeutics Business Overview
  10.5.5 JW Therapeutics Recent Developments
10.6 FOSUNKite
  10.6.1 FOSUNKite CAR T-Cell-Based Drug Basic Information
  10.6.2 FOSUNKite CAR T-Cell-Based Drug Product Overview
  10.6.3 FOSUNKite CAR T-Cell-Based Drug Product Market Performance
  10.6.4 FOSUNKite Business Overview
  10.6.5 FOSUNKite Recent Developments
10.7 CARsgen Therapeutics
  10.7.1 CARsgen Therapeutics CAR T-Cell-Based Drug Basic Information
  10.7.2 CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
  10.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product Market Performance
  10.7.4 CARsgen Therapeutics Business Overview
  10.7.5 CARsgen Therapeutics Recent Developments
10.8 Autolus Therapeutics
  10.8.1 Autolus Therapeutics CAR T-Cell-Based Drug Basic Information
  10.8.2 Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
  10.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product Market Performance
  10.8.4 Autolus Therapeutics Business Overview
  10.8.5 Autolus Therapeutics Recent Developments
10.9 Sorrento Therapeutics
  10.9.1 Sorrento Therapeutics CAR T-Cell-Based Drug Basic Information
  10.9.2 Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
  10.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product Market Performance
  10.9.4 Sorrento Therapeutics Business Overview
  10.9.5 Sorrento Therapeutics Recent Developments
10.10 Mustang Bio
  10.10.1 Mustang Bio CAR T-Cell-Based Drug Basic Information
  10.10.2 Mustang Bio CAR T-Cell-Based Drug Product Overview
  10.10.3 Mustang Bio CAR T-Cell-Based Drug Product Market Performance
  10.10.4 Mustang Bio Business Overview
  10.10.5 Mustang Bio Recent Developments
10.11 Bluebird Bio
  10.11.1 Bluebird Bio CAR T-Cell-Based Drug Basic Information
  10.11.2 Bluebird Bio CAR T-Cell-Based Drug Product Overview
  10.11.3 Bluebird Bio CAR T-Cell-Based Drug Product Market Performance
  10.11.4 Bluebird Bio Business Overview
  10.11.5 Bluebird Bio Recent Developments
10.12 Cellectis
  10.12.1 Cellectis CAR T-Cell-Based Drug Basic Information
  10.12.2 Cellectis CAR T-Cell-Based Drug Product Overview
  10.12.3 Cellectis CAR T-Cell-Based Drug Product Market Performance
  10.12.4 Cellectis Business Overview
  10.12.5 Cellectis Recent Developments
10.13 Allogene Therapeutics
  10.13.1 Allogene Therapeutics CAR T-Cell-Based Drug Basic Information
  10.13.2 Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
  10.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product Market Performance
  10.13.4 Allogene Therapeutics Business Overview
  10.13.5 Allogene Therapeutics Recent Developments
10.14 Celyad
  10.14.1 Celyad CAR T-Cell-Based Drug Basic Information
  10.14.2 Celyad CAR T-Cell-Based Drug Product Overview
  10.14.3 Celyad CAR T-Cell-Based Drug Product Market Performance
  10.14.4 Celyad Business Overview
  10.14.5 Celyad Recent Developments

11 CAR T-CELL-BASED DRUG MARKET FORECAST BY REGION

11.1 Global CAR T-Cell-Based Drug Market Size Forecast
11.2 Global CAR T-Cell-Based Drug Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe CAR T-Cell-Based Drug Market Size Forecast by Country
  11.2.3 Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region
  11.2.4 South America CAR T-Cell-Based Drug Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Consumption of CAR T-Cell-Based Drug by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)

12.1 Global CAR T-Cell-Based Drug Market Forecast by Type (2025-2032)
  12.1.1 Global Forecasted Sales of CAR T-Cell-Based Drug by Type (2025-2032)
  12.1.2 Global CAR T-Cell-Based Drug Market Size Forecast by Type (2025-2032)
  12.1.3 Global Forecasted Price of CAR T-Cell-Based Drug by Type (2025-2032)
12.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2025-2032)
  12.2.1 Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application
  12.2.2 Global CAR T-Cell-Based Drug Market Size (M USD) Forecast by Application (2025-2032)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CAR T-Cell-Based Drug Market Size Comparison by Region (M USD)
Table 5. Global CAR T-Cell-Based Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global CAR T-Cell-Based Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global CAR T-Cell-Based Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell-Based Drug as of 2022)
Table 10. Global Market CAR T-Cell-Based Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers CAR T-Cell-Based Drug Sales Sites and Area Served
Table 12. Manufacturers CAR T-Cell-Based Drug Product Type
Table 13. Global CAR T-Cell-Based Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CAR T-Cell-Based Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CAR T-Cell-Based Drug Market Challenges
Table 22. Global CAR T-Cell-Based Drug Sales by Type (K MT)
Table 23. Global CAR T-Cell-Based Drug Market Size by Type (M USD)
Table 24. Global CAR T-Cell-Based Drug Sales (K MT) by Type (2019-2024)
Table 25. Global CAR T-Cell-Based Drug Sales Market Share by Type (2019-2024)
Table 26. Global CAR T-Cell-Based Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global CAR T-Cell-Based Drug Market Size Share by Type (2019-2024)
Table 28. Global CAR T-Cell-Based Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global CAR T-Cell-Based Drug Sales (K MT) by Application
Table 30. Global CAR T-Cell-Based Drug Market Size by Application
Table 31. Global CAR T-Cell-Based Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global CAR T-Cell-Based Drug Sales Market Share by Application (2019-2024)
Table 33. Global CAR T-Cell-Based Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global CAR T-Cell-Based Drug Market Share by Application (2019-2024)
Table 35. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global CAR T-Cell-Based Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global CAR T-Cell-Based Drug Sales Market Share by Region (2019-2024)
Table 38. North America CAR T-Cell-Based Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe CAR T-Cell-Based Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific CAR T-Cell-Based Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America CAR T-Cell-Based Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa CAR T-Cell-Based Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global CAR T-Cell-Based Drug Production (K MT) by Region (2019-2024)
Table 44. Global CAR T-Cell-Based Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global CAR T-Cell-Based Drug Revenue Market Share by Region (2019-2024)
Table 46. Global CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China CAR T-Cell-Based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Novartis CAR T-Cell-Based Drug Basic Information
Table 52. Novartis CAR T-Cell-Based Drug Product Overview
Table 53. Novartis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Novartis Business Overview
Table 55. Novartis CAR T-Cell-Based Drug SWOT Analysis
Table 56. Novartis Recent Developments
Table 57. Gilead Sciences CAR T-Cell-Based Drug Basic Information
Table 58. Gilead Sciences CAR T-Cell-Based Drug Product Overview
Table 59. Gilead Sciences CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Gilead Sciences Business Overview
Table 61. Gilead Sciences CAR T-Cell-Based Drug SWOT Analysis
Table 62. Gilead Sciences Recent Developments
Table 63. Bristol-Myers Squibb CAR T-Cell-Based Drug Basic Information
Table 64. Bristol-Myers Squibb CAR T-Cell-Based Drug Product Overview
Table 65. Bristol-Myers Squibb CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Bristol-Myers Squibb CAR T-Cell-Based Drug SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. J and J CAR T-Cell-Based Drug Basic Information
Table 70. J and J CAR T-Cell-Based Drug Product Overview
Table 71. J and J CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. J and J Business Overview
Table 73. J and J Recent Developments
Table 74. JW Therapeutics CAR T-Cell-Based Drug Basic Information
Table 75. JW Therapeutics CAR T-Cell-Based Drug Product Overview
Table 76. JW Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. JW Therapeutics Business Overview
Table 78. JW Therapeutics Recent Developments
Table 79. FOSUNKite CAR T-Cell-Based Drug Basic Information
Table 80. FOSUNKite CAR T-Cell-Based Drug Product Overview
Table 81. FOSUNKite CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. FOSUNKite Business Overview
Table 83. FOSUNKite Recent Developments
Table 84. CARsgen Therapeutics CAR T-Cell-Based Drug Basic Information
Table 85. CARsgen Therapeutics CAR T-Cell-Based Drug Product Overview
Table 86. CARsgen Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. CARsgen Therapeutics Business Overview
Table 88. CARsgen Therapeutics Recent Developments
Table 89. Autolus Therapeutics CAR T-Cell-Based Drug Basic Information
Table 90. Autolus Therapeutics CAR T-Cell-Based Drug Product Overview
Table 91. Autolus Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Autolus Therapeutics Business Overview
Table 93. Autolus Therapeutics Recent Developments
Table 94. Sorrento Therapeutics CAR T-Cell-Based Drug Basic Information
Table 95. Sorrento Therapeutics CAR T-Cell-Based Drug Product Overview
Table 96. Sorrento Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Sorrento Therapeutics Business Overview
Table 98. Sorrento Therapeutics Recent Developments
Table 99. Mustang Bio CAR T-Cell-Based Drug Basic Information
Table 100. Mustang Bio CAR T-Cell-Based Drug Product Overview
Table 101. Mustang Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Mustang Bio Business Overview
Table 103. Mustang Bio Recent Developments
Table 104. Bluebird Bio CAR T-Cell-Based Drug Basic Information
Table 105. Bluebird Bio CAR T-Cell-Based Drug Product Overview
Table 106. Bluebird Bio CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Bluebird Bio Business Overview
Table 108. Bluebird Bio Recent Developments
Table 109. Cellectis CAR T-Cell-Based Drug Basic Information
Table 110. Cellectis CAR T-Cell-Based Drug Product Overview
Table 111. Cellectis CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Cellectis Business Overview
Table 113. Cellectis Recent Developments
Table 114. Allogene Therapeutics CAR T-Cell-Based Drug Basic Information
Table 115. Allogene Therapeutics CAR T-Cell-Based Drug Product Overview
Table 116. Allogene Therapeutics CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Allogene Therapeutics Business Overview
Table 118. Allogene Therapeutics Recent Developments
Table 119. Celyad CAR T-Cell-Based Drug Basic Information
Table 120. Celyad CAR T-Cell-Based Drug Product Overview
Table 121. Celyad CAR T-Cell-Based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Celyad Business Overview
Table 123. Celyad Recent Developments
Table 124. Global CAR T-Cell-Based Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global CAR T-Cell-Based Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America CAR T-Cell-Based Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America CAR T-Cell-Based Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe CAR T-Cell-Based Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe CAR T-Cell-Based Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific CAR T-Cell-Based Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific CAR T-Cell-Based Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America CAR T-Cell-Based Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America CAR T-Cell-Based Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa CAR T-Cell-Based Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa CAR T-Cell-Based Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global CAR T-Cell-Based Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global CAR T-Cell-Based Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global CAR T-Cell-Based Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global CAR T-Cell-Based Drug Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global CAR T-Cell-Based Drug Market Size Forecast by Application (2025-2032) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of CAR T-Cell-Based Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CAR T-Cell-Based Drug Market Size (M USD), 2019-2032
Figure 5. Global CAR T-Cell-Based Drug Market Size (M USD) (2019-2032)
Figure 6. Global CAR T-Cell-Based Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CAR T-Cell-Based Drug Market Size by Country (M USD)
Figure 11. CAR T-Cell-Based Drug Sales Share by Manufacturers in 2023
Figure 12. Global CAR T-Cell-Based Drug Revenue Share by Manufacturers in 2023
Figure 13. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market CAR T-Cell-Based Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by CAR T-Cell-Based Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CAR T-Cell-Based Drug Market Share by Type
Figure 18. Sales Market Share of CAR T-Cell-Based Drug by Type (2019-2024)
Figure 19. Sales Market Share of CAR T-Cell-Based Drug by Type in 2023
Figure 20. Market Size Share of CAR T-Cell-Based Drug by Type (2019-2024)
Figure 21. Market Size Market Share of CAR T-Cell-Based Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CAR T-Cell-Based Drug Market Share by Application
Figure 24. Global CAR T-Cell-Based Drug Sales Market Share by Application (2019-2024)
Figure 25. Global CAR T-Cell-Based Drug Sales Market Share by Application in 2023
Figure 26. Global CAR T-Cell-Based Drug Market Share by Application (2019-2024)
Figure 27. Global CAR T-Cell-Based Drug Market Share by Application in 2023
Figure 28. Global CAR T-Cell-Based Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global CAR T-Cell-Based Drug Sales Market Share by Region (2019-2024)
Figure 30. North America CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America CAR T-Cell-Based Drug Sales Market Share by Country in 2023
Figure 32. U.S. CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada CAR T-Cell-Based Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico CAR T-Cell-Based Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe CAR T-Cell-Based Drug Sales Market Share by Country in 2023
Figure 37. Germany CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific CAR T-Cell-Based Drug Sales Market Share by Region in 2023
Figure 44. China CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 50. South America CAR T-Cell-Based Drug Sales Market Share by Country in 2023
Figure 51. Brazil CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa CAR T-Cell-Based Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa CAR T-Cell-Based Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa CAR T-Cell-Based Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global CAR T-Cell-Based Drug Production Market Share by Region (2019-2024)
Figure 62. North America CAR T-Cell-Based Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe CAR T-Cell-Based Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan CAR T-Cell-Based Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China CAR T-Cell-Based Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global CAR T-Cell-Based Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global CAR T-Cell-Based Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global CAR T-Cell-Based Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global CAR T-Cell-Based Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global CAR T-Cell-Based Drug Sales Forecast by Application (2025-2032)
Figure 71. Global CAR T-Cell-Based Drug Market Share Forecast by Application (2025-2032)